GGrantIndex
← Search

Checkpoint inhibitor treatment for EBV+ lymphoma among HIV+ individuals

$301,675ZIAFY2024CANIH

Division Of Basic Sciences - Nci

Investigators

View original record on NIH RePORTER →
Checkpoint inhibitor treatment for EBV+ lymphoma among HIV+ individuals · GrantIndex